Advertisement

Government & Regulation

U.S. lawmakers are pushing the FDA to approve MDMA, more commonly known as ecstasy or molly, to treat post-traumatic stress disorder. 

Advertisement

The Joint Commission is updating its accreditation manual for behavioral health and human services providers to include an updated definition of "restraint," among other changes. 

Advertisement